title: Peptides and neurotransmission in the central nervous system.
abstract: Radioimmunoassays of brain extracts have shown that several peptides occur in high concentrations in the CNS. The releasing-factor peptides TRF, LRF, somatostatin, CRF and GRF have the highest concentration in the hypothalamic extracts. High levels of somatostatin, CCK octapeptide, neuropeptide Y (NPY) and vasoactive intestinal peptide (VIP) are found in cortical extracts. Substance P, CCK, NPY, and enkephalins are present in high concentrations in basal ganglia and mesolimbic areas. Pharmacological doses of these peptides result in several behavioural and vegetative effects. Immunocytochemical studies show that the CNS peptides are localised in neurones and in synaptic vesicles. In vitro studies with brain tissues show that peptides are capable of modifying the ongoing classical neurotransmission. In depressive patients several neuropeptides (CCK, CRF and NPY) have been shown to have low CSF levels. Patients dying of senile dementia have low cortical levels of somatostatin, CRF and substance P. In schizophrenic patients CCK peptides have shown to improve some symptoms. At present the therapeutic potentials of peptides are poorly known. More studies are required to understand their role in neurotransmission and related pathological states.
authors.affiliation: Department of Physiology, University of Oulu, Finland.
authors.forename: M
authors.initials: M
authors.lastname: Tuominen
authors.forename: J
authors.initials: J
authors.lastname: Leppäluoto
mesh_terms: D000818:Animals; D002490:Central Nervous System / Q000032:analysis* / Q000502:physiology; D006801:Humans; D009479:Neuropeptides / Q000032:analysis*; D009435:Synaptic Transmission
chemical_list: D009479:Neuropeptides